利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

9 条记录 (耗时 0.018 秒)

    SEPARATOR FOR VALVE REGULATED LEAD-ACID BATTERY, AND VALVE REGULATED LEAD-ACID BATTERY
    1.
    发明申请
    SEPARATOR FOR VALVE REGULATED LEAD-ACID BATTERY, AND VALVE REGULATED LEAD-ACID BATTERY 审中-公开
    阀门调节铅酸电池分离器和阀门调节铅酸电池

    公开(公告)号：US20130101887A1

    公开(公告)日：2013-04-25

    申请号：US13696883

    申请日：2011-04-27

    申请人： Shoji Sugiyama ,  Keita Mori

    发明人： Shoji Sugiyama ,  Keita Mori

    IPC分类号： H01M2/16

    CPC分类号： H01M2/1613 ,  H01M2/1686 ,  H01M10/06

    摘要： A separator for a valve regulated lead-acid battery comprises a paper sheet made by a wet papermaking process, mainly made of glass microfibers, wherein the separator is a structure having a three-layer laminated structure which comprises two thin-fiber layers and one thick-fiber layer, wherein the two thin-fiber layers cover both surfaces of the thick-fiber layer in the thicknesswise direction of the separator to constitute the three-layer laminated structure, wherein each of the thin-fiber layers is made of glass fibers having an average fiber diameter of 0.4 to 1.0 μm as the glass microfibers and has an average pore diameter of 3.5 μm or less, and the thick-fiber layer is made of glass fibers having an average fiber diameter of 1.3 to 4.0 μm as the glass microfibers and has an average pore diameter which is 4.0 μm or more and which is 1.5 times or more that of the thin-fiber layer, wherein the average fiber diameter of the glass fibers in the all layers of the separator is 1.2 μm or more, and the thickness ratio of the thin-fiber layers to the thick-fiber layer in the all layers of the separator is 10/90 to 50/50. In the valve regulated lead-acid battery, both the improvement of the compressive force lowering prevention and the improvement of the electrolyte stratification prevention can be achieved, improving the movement property of the electrolyte within the separator.

    摘要翻译： 用于阀调节铅酸蓄电池的隔板包括主要由玻璃微纤维制成的湿造纸工艺制成的纸张，其中隔板是具有三层层压结构的结构，其中包括两层薄纤维层和一层厚度 其中所述两个薄纤维层在所述隔膜的厚度方向上覆盖所述厚纤维层的两个表面以构成所述三层层压结构，其中每个所述薄纤维层由玻璃纤维制成，所述玻璃纤维具有 作为玻璃微纤维的平均纤维直径为0.4〜1.0μm，平均孔径为3.5μm以下，厚纤维层由平均纤维直径为1.3〜4.0μm的玻璃纤维制成，作为玻璃微纤维 平均孔径为4.0μm以上，为薄纤维层的1.5倍以上，其中隔膜的各层中的玻璃纤维的平均纤维直径为1.2μm 以上，并且隔膜的全部层中的薄纤维层与厚纤维层的厚度比为10/90〜50/50。 在阀调节铅酸电池中，可以实现防止压缩力降低的改善和防止电解质分层的改善，从而提高隔膜内电解液的运动性能。

    SEPARATOR FOR VALVE REGULATED LEAD-ACID BATTERY, AND VALVE REGULATED LEAD-ACID BATTERY
    2.
    发明申请
    SEPARATOR FOR VALVE REGULATED LEAD-ACID BATTERY, AND VALVE REGULATED LEAD-ACID BATTERY 审中-公开
    阀门调节铅酸电池分离器和阀门调节铅酸电池

    公开(公告)号：US20110217583A1

    公开(公告)日：2011-09-08

    申请号：US13128069

    申请日：2009-11-11

    申请人： Shoji Sugiyama ,  Keita Mori

    发明人： Shoji Sugiyama ,  Keita Mori

    IPC分类号： H01M2/16

    CPC分类号： H01M2/1613 ,  H01M2/1686 ,  H01M10/10 ,  H01M10/121

    摘要： It is an object of the present invention to provide a separator which can improve the valve regulated lead-acid battery both in the pressure lowering prevention effect and the electrolyte stratification prevention effect, and a valve regulated lead-acid battery using the same.The separator for the valve regulated lead-acid battery of the invention is a separator for a valve regulated lead-acid battery, comprising a paper sheet manufactured by a wet papermaking process mainly made of fine glass fibers, which is characterized in that the separator is a structure in which a thin fiber layer comprising glass fibers having an average fiber diameter of 0.5 to 0.8 μm as the fine glass fibers and a thick fiber layer comprising glass fibers having an average fiber diameter of 1.3 to 1.9 μm as the fine glass fibers are laminated in the thicknesswise direction of the separator so that the one thick fiber layer is covered with the two thin fiber layers from both sides to constitute a three-layer laminated structure, wherein the average fiber diameter of the glass fibers in the all layers is 1.1 μm or more, wherein the thickness ratio of the thin fiber layers to the thick fiber layer in the all layers is 25/75 to 50/50.

    摘要翻译： 本发明的目的是提供一种能够在降低防止效果和电解质分层防止效果的同时改善阀调节铅酸蓄电池的隔膜，以及使用该隔板的阀调节铅酸蓄电池。 本发明的阀调节铅酸蓄电池用隔膜是用于阀调节铅酸蓄电池的隔板，其特征在于，所述隔膜是由主要由细玻璃纤维制成的湿法造纸工艺制成的纸片， 将作为细玻璃纤维的平均纤维直径为0.5〜0.8μm的玻璃纤维的薄纤维层和作为细玻璃纤维的平均纤维直径为1.3〜1.9μm的玻璃纤维的厚纤维层构成为如下结构： 层压在隔板的厚度方向上，使得一个厚纤维层从两侧被两个薄纤维层覆盖以构成三层层压结构，其中所有层中的玻璃纤维的平均纤维直径为1.1 μm以上，其中，所有层中的薄纤维层与厚纤维层的厚度比为25/75〜50/50。

    Use of materials for treatment of central nervous system lesions
    3.
    发明授权
    Use of materials for treatment of central nervous system lesions 有权
    使用材料治疗中枢神经系统病变

    公开(公告)号：US08092792B2

    公开(公告)日：2012-01-10

    申请号：US12462143

    申请日：2009-07-30

    申请人： Mari Dezawa ,  Keita Mori

    发明人： Mari Dezawa ,  Keita Mori

    IPC分类号： A61K35/12

    CPC分类号： A61K35/30

    摘要： Disclosed are methods and materials for treatment of central nervous system lesions. Preferred methods and materials comprise neuronal precursor cells and/or marrow adherent stem cell-derived neuronal cells.

    摘要翻译： 公开了用于治疗中枢神经系统病变的方法和材料。 优选的方法和材料包括神经元前体细胞和/或骨髓粘附的干细胞衍生的神经元细胞。

    Use of materials for treatment of central nervous system lesions
    4.
    发明申请
    Use of materials for treatment of central nervous system lesions 有权
    使用材料治疗中枢神经系统病变

    公开(公告)号：US20100034790A1

    公开(公告)日：2010-02-11

    申请号：US12462143

    申请日：2009-07-30

    申请人： Mari Dezawa ,  Keita Mori

    发明人： Mari Dezawa ,  Keita Mori

    IPC分类号： A61K35/12

    CPC分类号： A61K35/30

    摘要： Disclosed are methods and materials for treatment of central nervous system lesions. Preferred methods and materials comprise neuronal precursor cells and/or marrow adherent stem cell-derived neuronal cells.

    摘要翻译： 公开了用于治疗中枢神经系统病变的方法和材料。 优选的方法和材料包括神经元前体细胞和/或骨髓粘附的干细胞衍生的神经元细胞。

    Use of materials for treatment of central nervous system lesions
    6.
    发明申请
    Use of materials for treatment of central nervous system lesions 审中-公开
    使用材料治疗中枢神经系统病变

    公开(公告)号：US20060216276A1

    公开(公告)日：2006-09-28

    申请号：US11368919

    申请日：2006-03-06

    申请人： Mari Dezawa ,  Keita Mori

    发明人： Mari Dezawa ,  Keita Mori

    IPC分类号： A61K35/30 ,  C12N5/08

    CPC分类号： A61K35/30

    摘要： Disclosed are methods and materials for treatment of central nervous system lesions. Preferred methods and materials comprise neuronal precursor cells and/or marrow adherent stem cell-derived neuronal cells.

    摘要翻译： 公开了用于治疗中枢神经系统病变的方法和材料。 优选的方法和材料包括神经元前体细胞和/或骨髓粘附的干细胞衍生的神经元细胞。

    Transdermal preparation
    7.
    发明授权
    Transdermal preparation 有权
    透皮制剂

    公开(公告)号：US08702664B2

    公开(公告)日：2014-04-22

    申请号：US13201999

    申请日：2010-02-09

    申请人： Satoshi Amano ,  Tomohiro Shinoda ,  Natsumi Kase ,  Keita Mori

    发明人： Satoshi Amano ,  Tomohiro Shinoda ,  Natsumi Kase ,  Keita Mori

    IPC分类号： A61M35/00

    CPC分类号： A61K9/7084 ,  A61K31/138

    摘要： By providing a non-liquid drug reservoir layer 2 having first and second principal surfaces and containing a drug and a polymer that is to be a base, a drug permeation layer 4 disposed at the first principal surface side of the drug reservoir layer 2 and being lower in permeability of the drug than the drug reservoir layer 2, and a first backing 3 with a bending resistance of 10 to 80 mm that is formed so as to cover a side surface of the drug reservoir layer, skin irritation can be reduced.

    摘要翻译： 通过设置具有第一主表面和第二主表面并且含有药物和要成为基底的聚合物的非液体药物储存层2，设置在药物储存层2的第一主表面侧的药物渗透层4， 药物的透过率低于药物贮存层2，并且形成为覆盖药物储存层的侧面的抗弯曲性为10〜80mm的第一背衬3，因此可以降低皮肤刺激性。

    TRANSDERMAL PREPARATION
    8.
    发明申请
    TRANSDERMAL PREPARATION 有权
    变态准备

    公开(公告)号：US20120029446A1

    公开(公告)日：2012-02-02

    申请号：US13201999

    申请日：2010-02-09

    申请人： Satoshi Amano ,  Tomohiro Shinoda ,  Natsumi Kase ,  Keita Mori

    发明人： Satoshi Amano ,  Tomohiro Shinoda ,  Natsumi Kase ,  Keita Mori

    IPC分类号： A61M35/00

    CPC分类号： A61K9/7084 ,  A61K31/138

    摘要： By providing a non-liquid drug reservoir layer 2 having first and second principal surfaces and containing a drug and a polymer that is to be a base, a drug permeation layer 4 disposed at the first principal surface side of the drug reservoir layer 2 and being lower in permeability of the drug than the drug reservoir layer 2, and a first backing 3 with a bending resistance of 10 to 80 mm that is formed so as to cover a side surface of the drug reservoir layer, skin irritation can be reduced.

    摘要翻译： 通过设置具有第一主表面和第二主表面并且含有药物和要成为基底的聚合物的非液体药物储存层2，设置在药物储存层2的第一主表面侧的药物渗透层4， 药物的透过率低于药物贮存层2，并且形成为覆盖药物储存层的侧面的抗弯曲性为10〜80mm的第一背衬3，因此可以降低皮肤刺激性。